Related Experiment Video
Updated: Jul 16, 2026
05:29
Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
A role for caspase-1 in heart failure
Sabine Merkle1, Stefan Frantz, Michael P Schön
1Rudolf Virchow Center, Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine, Wuerzburg, Germany.
Circulation Research
|February 17, 2007
Summary
Caspase-1, a proapoptotic protein, drives heart failure by directly inducing cardiomyocyte apoptosis. Deleting caspase-1 protects against heart failure and ischemia/reperfusion injury, revealing its critical role in cardiac disease progression.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cell Death Pathways
Background:
- Cardiomyocyte apoptosis contributes to heart failure progression.
- The role of proinflammatory caspases, like caspase-1, in cardiac function is not well understood.
- Previous research suggested a proinflammatory role for caspase-1.
Purpose of the Study:
- To investigate the role of caspase-1 in the heart, particularly in the context of heart failure.
- To determine if caspase-1 has a proapoptotic or proinflammatory function in cardiomyocytes.
- To elucidate the therapeutic potential of targeting caspase-1 in cardiac diseases.
Main Methods:
- Gene array analysis and protein expression studies in murine and human heart failure models.
- Generation of transgenic mice with cardiomyocyte-specific caspase-1 overexpression.
- Utilizing genetically modified mice (caspase-1 deficient) in myocardial infarction and ischemia/reperfusion injury models.
- In vitro studies using primary rat cardiomyocytes.
Main Results:
- Caspase-1 expression is upregulated in murine and human heart failure.
- Overexpression of caspase-1 in cardiomyocytes induced apoptosis and heart failure without significant inflammation or IL-1beta/IL-18 production.
- Deletion of endogenous caspase-1 conferred protection against myocardial infarction and ischemia/reperfusion-induced injury.
- Caspase-1 mediates cardiomyocyte apoptosis via activation of caspases-3 and -9.
Conclusions:
- Caspase-1 plays a primary proapoptotic role in cardiomyocytes, distinct from its previously suggested proinflammatory function.
- Caspase-1-mediated cardiomyocyte apoptosis contributes significantly to the progression of heart failure.
- Targeting caspase-1 may offer a novel therapeutic strategy for heart failure and related cardiac conditions.
Related Concept Videos
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...